Beta Bionics, Inc.
BBNX
$10.20
$0.303.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -66.44M | -73.20M | -77.84M | -73.37M | -70.96M |
| Total Depreciation and Amortization | 3.26M | 2.88M | 2.47M | 2.40M | 2.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.13M | 28.39M | 29.33M | 26.06M | 26.27M |
| Change in Net Operating Assets | -10.73M | -8.99M | -10.53M | -12.55M | -13.74M |
| Cash from Operations | -54.78M | -50.93M | -56.58M | -57.46M | -56.10M |
| Capital Expenditure | -6.34M | -5.30M | -3.96M | -4.59M | -3.32M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.50M | -157.51M | -189.17M | -182.78M | -186.92M |
| Cash from Investing | 38.16M | -162.81M | -193.13M | -187.37M | -190.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.38M | 214.87M | 213.85M | 211.25M | 211.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 59.66M | 59.66M | 59.66M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2.81M | -4.03M | -4.15M |
| Cash from Financing | 4.38M | 214.87M | 270.71M | 266.88M | 266.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.25M | 1.14M | 21.00M | 22.05M | 20.38M |